Skip to content
AnilSka

Insights

Notes from the platform.

A slowly growing library of letters, essays and observations from AnilSka — on medicine, systems, capital and the long horizons that make institutions worth building.

Pharmaceutical innovation

Why combination products will reshape regulated markets

The regulated pathways of the next decade reward teams that treat device, drug and data as a single therapeutic system — not three separate submissions.

Read — coming soon
Investment thinking

The quiet discipline of holding

A note on why we default to stewardship rather than exit, what it costs to mean it, and how holding periods change what an owner is willing to build.

Read — coming soon
AI & systems architecture

Systems architecture as a governance instrument

How the shape of a system quietly determines what its operators are permitted to do — and why governance work belongs, in part, inside the architecture itself.

Read — coming soon
Founder letters

Letter from the founders: on wind and patience

A first letter from the founders of AnilSka on the meaning of the name, the horizons we work on, and what our founders can expect from us in return.

Read — coming soon
Global partnerships

Cross-border knowledge transfer as an asset class

Corridors of trust between Australia, Canada and Sri Lanka behave less like transactions and more like slowly appreciating infrastructure.

Read — coming soon
Pharmaceutical innovation

AI in regulated healthcare: restraint as strategy

In regulated healthcare the winning move is often the deferred one — restraint about where AI is inserted, and where practitioner judgement is protected.

Read — coming soon